chrisvoncsefalvay/vaers-outcomes huggingface dataset:
13 minutes after getting the injection, my left side of my face, from my eyebrow down to the side of my nose down to the middle of my chin down to the left side of my neck and all the way down my arm to my fingers went numb. I went to the paramedic tent and they checked my vitals, O2 levels, blood sugar levels, temperature, pulse, and breathing. It wasn't painful. It was more of a tingly annoying sensation, example would be receiving novocaine at the dentist. After 40 minutes I started getting feeling back. I was then let go to go home.  My second dose of the covid-19 moderna vaccine I had a similar reaction but not as bad. I did go numb, but the numbness started in the middle of my chin and followed my jawline up to my ear. I got a little bit patches of numbness in my neck. I got numbness at the back of my arm from where I got the injection. Again the numbness started around 13 minutes and I started getting feeling back after 30 minutes.
nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 (Lot number: ER8735) at the age of 77 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 30Apr2021, outcome "not recovered", described as "nausea".  Additional information: The reporter stated she had been experiencing nausea that came in waves. The nausea really started about 3 hours after she received the vaccine. Investigation assessment was not reported.   No follow-up attempts are possible. No further information is expected.
Noticed fever of 101 and extreme fusiness, glossy eyes, red cheeks and called doctors office. Nurse advises me that this reaction is normal for 24-48 hours. I administer Motrin and Tylenol through the next 24 hours. On 10/22 around 6pm fever climbs to 103.2 so I give Motrin and put her to bed at 9pm. At 1 am child wakes up screaming, inconsolable, high fever of 103 again, hoarsness in voice, stifness. I administer Motrin again and take her to the ER at 2:30 AM. The doctors there tell me she has an upper respiratory infection and they highly doubt this has anything to do with the shots. She should be fine but to go back if the fevers dont stop. Throughout the next 24 hours I switch off between Motrin and Tylenol and the fevers and inconsolable crying do not stop so I take her to her doctors urgent care on 10/24/2010 at 1:30 PM. They say they do not think this has anything to do with the shots and that it must be a virus. Doctor does an x-ray of her chest and sends me to the hospital for blood work. On Monday 10/25/2010 the doctor calls and says the radiologist is seeing something that is indicative of acute pneumonia on her X-Ray and that they are going to start her on antibiotics. The fevers broke on Monday and child seemed to be feeling better but was very pale, cold and sounded very hoarse with coughing. On Tuesday the azithromycin is given at 1pm and around 4pm child develops a splochy rash on neck, stomach, and back. I call the doctors office and they advise me to take her to urgent care again!
On about 15th of May I got what I thought was the flu. By Monday I felt worse so I went to the urgent care and tested me for the flu and Covid, and I had Covid. I went home and felt miserable for a few more days and slowly got back to work. I had body aches, fever at least 102.5, uncomfortable sore throat with extreme sinus pain that felt like a sinus infection, could not eat felt nausea, and pretty bad headache that came with the sinus discomfort. Level of severity was 10 I was quite miserable. Also had weakness and fatigue and slept 20hrs a day and could barely walk around the house. And I'm still extremely tired today, and still brain fog. They gave me some medicine that didn't agree with me and I got a serious skin rash.
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 31-Aug-2020 and the estimated date of delivery was 13-Jun-2021. On 13-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-seventh week of the pregnancy.  On 13-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information has been received from a consumer reporting on her male husband who on 17-SEP-2007 was vaccinated with a dose of zoster vaccine live (Oka/Merck). On 18-SEP-2007 ("the next day") the patient "broke out with a bad rash and has been having outbreaks ever since". The patient sought medical attention via an office visit. At the time of the report the patient's status was not recovered. Additional information has been requested.
Red eyes, headache, chills, throat felt like it was closing fever 100.5, body aches sx started approx 4hr after vaccine given IM injection triamcinolone here approximately 530pm.
Chills,  Muscle or body aches,  Runny nose/Congestion,  Sore throat, Cough,  Shortness of breath or difficulty breathing,  Chest pain,  Fatigue or tiredness, pneumonia in both lungs
Approximately 20 minutes post vaccination -Patient had rash in bilateral antecubital region, erythematous base with pruritus. Patient stated she did not have this rash prior to vaccine, no reaction noted on injection site, Benadryl given with good effect. Post Benadryl pruritus resolved and erythema improving on bilateral antecubital regions and patient discharged home.
Hot/red 7 x 7 cm patch on upper (L) thigh - not tender, no treatment needed.
has stomach pain; VOMITING; he got dizziness (got worse now); stiff neck (getting better); he got very tired; A spontaneous report was received from a consumer concerning a 83-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events he got very tired/fatigue, he got dizziness, stiff neck/musculoskeletal stiffness, vomiting, has stomach pain.  The patient's medical history was not provided. Concomitant medications reported were Metformin, dulaglutide, quinapril, HCTZ for drug use for unknown indication.  On 12 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 00SM20A) intramuscularly for prophylaxis of COVID-19 infection.  On 14 Feb 2021, the patient experienced the event(s) he got very tired. On 20 Feb 2021, the patient experienced the event(s) he got dizziness (got worse now), stiff neck (getting better). On 23 Feb 2021, the patient experienced the event(s) vomiting, has stomach pain.  Treatment details included acetaminophen for stiff neck.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), he got very tired, he got dizziness, stiff neck ,vomiting, has stomach pain was unknown.
(R) thigh with erythematous papulovesicular lesion about 9 cm in diameter - small patch of vesicle lesion - reaction encompasses injection of both vaccine.
Patient came in office today with redness at injection site down his arm. Swelling and warm to touch. He was diagnosed and treated with KEFLEX 250/5mL 2 tsp bid x 10 days for cellulitis.
Felt hot and cold. Couldn't sleep well waking up every few hours. Vomited after trying to eat breakfast around 9:30am. Feet were numb and tingly. All symptoms went away by 12:45-1pm except the numb and tingly  feet. That lasted a few days and then went away for about a week. Came back and lasted for 3 months. Finally going away now.
hives on 11/7/2019, histamine blockers, otc anti itch medication
Patient has not receive second dose and way passed by 42 days; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not receive second dose and way passed by 42 days) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not receive second dose and way passed by 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not receive second dose and way passed by 42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history were reported.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.            Patient stated that she increased the ibuprofen dosage.   This case was linked to MOD-2021-385800, MOD-2021-385823 (Patient Link).
This is a spontaneous report from a contactable consumer who reported for her son. A male patient of an unspecified age and ethnicity received TRUMENBA and GARDASIL, both via an unspecified route of administration on 27Mar2015. The patient medical history and concomitant medications were not reported. On unknown date, the patient experienced little bit of redness with outcome of unknown and pain in arm with outcome of recovered. The reporter mentioned that she did not take her son to any doctor for the pain that occurred after vaccination.
Sickness; Clostridium difficile infection; FACILITATED COLLECT This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): 21K-163-4129526-00.  A 54 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 10Oct2021 (Batch/Lot number: unknown) at the age of 54 years as dose 2, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (ongoing) (Lot number: 1154004) at citrate free for colitis ulcerative. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose), administration date: 01Sep2021, when the patient was 53 years old, for COVID-19 Vaccination. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. On 01Sep2021, patient received 1st dose COVID-19 Vaccine manufactured by Pfizer/BioNTech. On 10Oct2021, patient received 2nd dose COVID-19 Vaccine manufactured by Pfizer/BioNTech. No known allergies. The following information was reported: CLOSTRIDIUM DIFFICILE INFECTION (medically significant) with onset 2021, outcome "recovering", described as "Clostridium difficile infection"; ILLNESS (non-serious) with onset Nov2021, outcome "unknown", described as "Sickness". The action taken for adalimumab was unknown. Clinical course: Solicited report from the USA by a consumer of a 54-year-old male with events of non-serious C-Diff and Sick with Humira (Adalimumab). There was no reported medical history. On an unknown date, the patient experienced C-Diff. In Nov2021, the patient experienced Sick.  The reporter's assessment of the causal relationship of the events with the suspect product was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
Seizure 10 minutes post vaccine, convulsions lasted 15-30 seconds.
This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. The patient's pertinent medical history and concomitant medications were not reported. on 01-JUN-2016, the patient was inadvertently administered a dose of VARIVAX (Lot # and expiry date were not reported). This patient was intended to receive a dose of ZOSTAVAX (no dose of ZOSTAVAX was administered). It was confirmed that no product confusion occurred. No adverse effects were reported. Additional information has been requested.
This is a spontaneous report from a contactable consumer or other non-HCP. A 48-year-old patient, of an unspecified gender, received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported, expiry date: unknown), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On an unspecified date, patient experienced headache, fever and body aches for 36 hours; with outcome of recovered on unspecific date. No follow-up attempts possible. Information about lot/batch number cannot be obtained.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 01-JUL-2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 07-JUL-2016, the patient was treated by a physician for a severe vesicular outbreak, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Injection Site tenderness / Injection Site Achy; Low grade fever; Malaise; This case was reported by a nurse via call center representative and described the occurrence of injection site tenderness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site tenderness, low grade fever and malaise. On an unknown date, the outcome of the injection site tenderness, low grade fever and malaise were unknown.   It was unknown if the reporter considered the injection site tenderness, low grade fever and malaise to be related to Shingrix.  Additional details were provided as follows: This case was reported by the Nurse for herself. The age at vaccination was not reported. The patient experienced site tenderness that was achy, a low grade fever and malaise after receiving vaccine. This case is 1 of the 4 linked cases, reported by the same reporter.
tested porsitive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested porsitive for COVID) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jul-2021, the patient experienced COVID-19 (tested porsitive for COVID). At the time of the report, COVID-19 (tested porsitive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2021, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were reported.  On 29-Jul-2021, patient received a Regeneron treatment (monoclonal antibodies for COVID).  Patient was not aware that he had to wait 90 days to get another dose.  Patient consider that probably got COVID before getting the vaccine.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-Aug-2021: Follow-up received and contains no new information.
Patient developed redness and induration to vaccine site the day after vaccine was given. Patient also had a 101.9 degree temperature. Benadryl was prescribed q6h x 24 hours. Follow up on 12/2/00 showed that symptoms had decreased to minimal erythema to site.
Information has been received from a physician concerning an 84 year old female with a sulf allergy, lymphoma, hypothyroidism and a history of splenectomy, chickenpox and hysterectomy who on 05-SEP-2007 was vaccinated right side with ZOSTER (Oka/Merck) (Product Lot # 657767/0740U).  Concomitant therapy included CELEBREX, NORVASC, lovastatin (manufacturer unknown), DYAZIDE, SYNTHROID, NEXIUM and DITROPAN.  On 09-OCT-2008 the patient experienced a full blown case of shingles and was seen in the office.  No rash was reported at the injection site.  The lesions began at the level of the T8 on the back and wrapped around the body to the breast/thoracic on the left side.  The symptom was worse in afternoon.  The physician collected cultures from Herpes Simplex Virus and ZOSTER Virus.  The patient's shingles persisted.  The patient was enrolled in the Varicella ZOSTER Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine VZV strain.  The sample was taken from lesion was collected on 09-OCT-2008.  The PCR result identified that VZV DNA was amplified and B-globin DNA was not amplied but also reported the specimen was adequate, wild type strain.  This is one of several reports from the same source.  Additional information has been requested.
Joint ache, headache, lack of sleep, lack of appetite, stomach ache, exhausted for weeks.
Welt - 4 X 4 cm allergic skin reaction CLAITIN/ZARTAC
Dermatographia type symptoms appeared about 13 days after booster shot. Light pressure or friction from any type of material (not just fingernails) results in hives. Constant itchiness that affects the whole body including the face. Prescription antihistamines and steroid cream to manage symptoms, but does not eliminate them. Condition has not improved on its own without using medication.
10 minutes after the vaccination I developed a vascular pain in the left calf. It is continuous and doesn?t stop but mild enough to be able to carry on with daily routine. At the time of writing this report 2.5 day passed since it started. On top of that 19 hours after the shot I had brief but scary 10-15 minutes episode of violent nausea+inability to catch a breath to the point I couldn?t produce a voice to call for help. The episode was severe enough for my housemates to get me ready for ER. After applying ice to my neck and head symptoms subsided enough for me to reconsider ER and just observe the further development.
headaches; hot flashes; cramping; fatigue; 2 weeks after getting my second shot I got an unusually heavy period that last 2 weeks along with hot flashes, cramping, fatigue, and headaches. I got the Mirena IUD in Sept 2020 and hadn't had any pe; 2 weeks after getting my second shot I got an unusually heavy period that last 2 weeks along with hot flashes, cramping, fatigue, and headaches. I got the Mirena IUD in Sept 2020 and hadn't had any pe; Other vaccine same date vaccine date: 01Mar2021; This is a spontaneous report from a contactable consumer (patient). A 24-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration in left arm on 01Mar2021 (at the age of 24-years-old) as DOSE 2, SINGLE for covid-19 immunisation and received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: E N6204), via an unspecified route of administration in left arm on 01Mar2021 at 02:00 (at the age of 24-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The medical history included known allergy to Penicillin and Mirena IUD in Sep2020 and hadn't had any periods since then or had any after, birth control for 5 years and never had a surprise period like this. Patient's concomitant medications were not reported. Patient had no other vaccine in four weeks or no other medications in two weeks. On 05Apr2021, at 12:00, 2 weeks after getting second shot the patient experienced an unusually heavy period that last 2 weeks along with hot flashes, cramping, fatigue, and headaches. Patient stated I got the Mirena IUD in Sep2020 and hadn't had any periods since then or had any after. I never had a period that heavy or with those symptoms before. I had been on birth control for 5 years and never had a surprise period like that before. Patient had not covid prior vaccination and tested COVID tested post vaccination. The patient underwent lab tests and procedures which included Nasal swab resulted negative on 21Apr2021 COVID test post vaccination. The patient did not receive any treatment for events. The  outcome of event were recovered on unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.
Pt. became dizzy several hrs. After shot became worse and had nausea & vomiting for a few days after shot. CT scan negative, blood work Neg. Dr. gave him med for vertigo & changed his BP med.
Rash, pruritic over body and arms; persistent after 1 week. Treatment with topical steroids